Tevogen Bio Holdings Inc.
TVGN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $154 | $230 | $174 | $183 |
| - Cash | $1 | $1 | $2 | $1 |
| + Debt | $3 | $8 | $5 | $3 |
| Enterprise Value | $156 | $237 | $177 | $185 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$6 | -$5 | -$10 | -$9 |
| % Margin | – | – | – | – |
| Net Income | -$6 | -$6 | -$10 | -$9 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.03 | -0.031 | -0.065 | -0.052 |
| % Growth | 2% | 53% | -25.2% | – |
| Operating Cash Flow | -$4 | -$3 | -$3 | -$3 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$4 | -$3 | -$3 | -$3 |